17 research outputs found
Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, α-antitrypsin, C8, and factor B
Serum protein types were determined in eight recipients and donors in cases of hepatic homotransplantation. A change from recipient type to donor type was observed for factor B, C8, orosomucoid, haptoglobin, transferrin, α1-antitrypsin, C3 and C6, but not for Gm and Inv immunoglobulin markers. The results indicate that all the proteins studied (except immunoglobulins) are produced primarily by the liver in vivo. © 1980
Recommended from our members
Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E
BACKGROUND: The definition of human MHC class I haplotypes through association of HLA-A, HLA-Cw and HLA-B has been used to analyze ethnicity, population migrations and disease association. RESULTS: Here, we present HLA-E allele haplotype association and population linkage disequilibrium (LD) analysis within the ~1.3 Mb bounded by HLA-B/Cw and HLA-A to increase the resolution of identified class I haplotypes. Through local breakdown of LD, we inferred ancestral recombination points both upstream and downstream of HLA-E contributing to alternative block structures within previously identified haplotypes. Through single nucleotide polymorphism (SNP) analysis of the MHC region, we also confirmed the essential genetic fixity, previously inferred by MHC allele analysis, of three conserved extended haplotypes (CEHs), and we demonstrated that commercially-available SNP analysis can be used in the MHC to help define CEHs and CEH fragments. CONCLUSION: We conclude that to generate high-resolution maps for relating MHC haplotypes to disease susceptibility, both SNP and MHC allele analysis must be conducted as complementary techniques
The Role of TNF-α in Mice with Type 1- and 2- Diabetes
Background: Previously, we have demonstrated that short-term treatment of new onset diabetic Non-obese diabetic (NOD) mice, mice that are afflicted with both type 1 (T1D) and type 2 (T2D) diabetes with either Power Mix (PM) regimen or alpha1 antitrypsin (AAT) permanently restores euglycemia, immune tolerance to self-islets and normal insulin signaling. Methodology and Principal Findings: To search for relevant therapeutic targets, we have applied genome wide transcriptional profiling and systems biology oriented bioinformatics analysis to examine the impact of the PM and AAT regimens upon pancreatic lymph node (PLN) and fat, a crucial tissue for insulin dependent glucose disposal, in new onset diabetic non-obese diabetic (NOD) mice. Systems biology analysis identified tumor necrosis factor alpha (TNF-) as the top focus gene hub, as determined by the highest degree of connectivity, in both tissues. In PLNs and fat, TNF- interacted with 53% and 32% of genes, respectively, associated with reversal of diabetes by previous treatments and was thereby selected as a therapeutic target. Short-term anti-TNF- treatment ablated a T cell-rich islet-invasive and beta cell-destructive process, thereby enhancing beta cell viability. Indeed anti-TNF- treatment induces immune tolerance selective to syngeneic beta cells. In addition to these curative effects on T1D anti-TNF-e33254 treatment restored in vivo insulin signaling resulting in restoration of insulin sensitivity. Conclusions: In short, our molecular analysis suggested that PM and AAT both may act in part by quenching a detrimental TNF- dependent effect in both fat and PLNs. Indeed, short-term anti-TNF- mAb treatment restored enduring euglycemia, self-tolerance, and normal insulin signaling
Recommended from our members
The Paternally Inherited Insulin Gene B Allele (1,428 FokI site) Confers Protection from Insulin-dependent Diabetes in Families
Several polymorphisms of the insulin gene and its flanking regions (INS region) are in linkage disequilibrium and confer susceptibility to insulin-dependent diabetes (IDDM). We have analysed INS AA and AB-BB genotypes at the 1,428 FokI site (3′ of the insulin gene) in 217 patients with IDDM, 402 non-diabetic first degree relatives negative for insulin (IAA) and islet cell autoantibodies (ICA), and 116 autoantibody positive (for ICA or IAA, or both) relatives of whom 39 became diabetic on follow-up. Most IDDM patients (83.4%, 181/217) had the AA genotype
vs. 50% (25/50) of the controls (
P<10
-6). Only 16.6% (36/217) of IDDM patients carried the AB genotype and none was BB homozygous, suggesting a protective effect of the B allele. By segregation analysis of the B allele in the IDDM offspring of informative families (only one AB parent) from the United States, the maternal B allele was inherited by 19/35 (54.2%) of the IDDM offspring. In contrast, only 4/26 (15.3%) of the IDDM offspring inherited the paternal B allele (
P=0.001), suggesting maternal imprinting of the INS region. Therefore, the INS B allele may be protective only when paternally inherited. Among the 39 of 116 autoantibody positive relatives who developed IDDM on follow-up, only five of them had the B allele. The frequency of the B allele in this group was much lower (12.8%, 5/39) than that observed in non-diabetic autoantibody positive relatives (32.5%, 25/77,
P=0.02). By lifetable analysis, autoantibody positive relatives with the B allele showed slower and lesser progression to IDDM than those without it (Log-rank test,
P=0.04). In conclusion, we find a protective effect of the paternally inherited B allele in diabetic families from the United States and in their autoantibody positive first degree relatives
The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1
HLA-DQB1 is widely considered to be the major histocompatibility complex (MHC) susceptibility gene for type 1 diabetes (T1D). However, since inheritance of the gene in T1D is recessive, the presence of the protectiveHLA-DQB1*0602 allele with normal nucleotide sequence in some patients raises the question of whetherHLA-DQB1 is not the susceptibility locus itself but merely a good marker.HLA-DQB1*0602 is part of a conserved extended haplotype (CEH) [HLA-B7, SC31, DR2] (B7, DR2) with fixed DNA over more than 1Mb of genomic DNA that normally carries a protective allele at the true susceptibility locus. We postulated that, in patients withHLA-DQB1*0602, the protective allele at the susceptibility locus has been replaced by a susceptibility allele through an ancient crossover at meiosis centromeric toHLA-DQB1. We analyzed single nucleotide polymorphisms (SNPs) distinguishing theHLA-DQA2 (the first expressed gene centromeric toHLA-DQB1) allele on the normal HLA-B7, DR2 CEH from those on susceptibility CEHs in T1D patients and controls withHLA-DQB1*0602. All but 1 of 20 healthy controlHLA-DQB1*0602 haplotypes had identical (consensus) first intronHLA-DQA2 5-SNP haplotypes. Fifteen of 19 patients withHLA-DQB1*0602 were homozygous for 1 or moreHLA-DQA2 SNPs differing from consensusHLA-DQA2 SNPs, providing evidence of crossover involving theHLA-DQA2 locus. The remaining 4 patients were heterozygous at all positions and therefore uninformative. The loss of dominant protection usually associated withHLA-DQB1*0602 haplotypes is consistent with a locus centromeric toHLA-DQB1 being a major determinant of MHC-associated susceptibility, and perhaps the true T1D susceptibility locus
Recommended from our members
The social relevance of philosophy
What is the social relevance of philosophy? Any answer to this question must involve at least three elements. First, we need to understand how philosophy has brought about social change in the past. Second, to dig into the question more deeply, we need to see how the definition of philosophy can be opened up. Thirdly, we need to critically examine and challenge some of the assumptions that might be hidden in the question. Once we have done all this, we can try to answer the question